NASDAQ: RTSNRetension Pharmaceuticals Inc Stock Ownership - Who owns Retension Pharmaceuticals?
Insider buying vs selling
Have Retension Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Franklin M. Berger | Director | 2026-10-13 | 10,000 | $12.00 | $120.00kBuy |
| Eric L. Keller | CEO | 2026-10-13 | 20,800 | $12.00 | $249.60kBuy |
RTSN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RTSN insiders and whales buy or sell their stock.
RTSN Shareholders
What type of owners hold Retension Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Eric L. Keller | 5.89% | 464,407 | $5.26M | Insider |
| Paul Sweetnam | 5.19% | 409,243 | $4.63M | Insider |
| Franklin M. Berger | 0.29% | 22,517 | $254.89k | Insider |
| Michael J. Berendt | 0.08% | 6,666 | $75.46k | Insider |
| Donald Olds | 0.07% | 5,637 | $63.81k | Insider |
| Sabine Bisson | 0.05% | 4,115 | $46.58k | Insider |
Retension Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.